What is the CVSS score of CVE-2017-17675?

CVE-2017-17675 has a CVSS 3.1 base score of 5.3 (Medium). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N. EPSS exploitation probability: 1.1%.

Remedy Mid Tier CVE-2017-17675

MEDIUM

Insertion of Sensitive Information into Log File (CWE-532)

2021-05-19 cve@mitre.org

Information Disclosure Remedy Mid Tier

5.3

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

5.3 MEDIUM

AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

Low

Integrity

None

Availability

None

Lifecycle Timeline

CVE Published

May 19, 2021 - 14:15 nvd

MEDIUM 5.3

DescriptionNVD

BMC Remedy Mid Tier 9.1SP3 is affected by log hijacking. Remote logging can be accessed by unauthenticated users, allowing for an attacker to hijack the system logs. This data can include user names and HTTP data.

AnalysisAI

BMC Remedy Mid Tier 9.1SP3 is affected by log hijacking. Rated medium severity (CVSS 5.3), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-532. BMC Remedy Mid Tier 9.1SP3 is affected by log hijacking. Remote logging can be accessed by unauthenticated users, allowing for an attacker to hijack the system logs. This data can include user names and HTTP data. Affected products include: Bmc Remedy Mid-Tier.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.